Medlab Clinical Ltd. (MDLB)

Medlab Clinical will go public soon, but the exact IPO date is still unknown.
IPO Price
Shares Offered
Deal Size
Chart not available yet
Data will show when the stock starts trading.
Market Cap 18.16M
Revenue (ttm) 1.54M
Net Income (ttm) -7.16M
Shares Out 4.08M
EPS (ttm) -1.75
PE Ratio n/a
Forward PE n/a
Dividend n/a
Ex-Dividend Date n/a
Volume n/a
Open n/a
Previous Close n/a
Day's Range n/a
52-Week Range n/a
Beta n/a
Analysts n/a
Price Target n/a
Earnings Date n/a

About MDLB

Medlab Clinical is an Australian biotechnology company that formulates innovative solutions and innovative consumer health care products to provide integrative patient care. Our aim is to disrupt the multi-billion-dollar market of delivery platform technologies for pharmaceutical products that are designed to treat pain and mental health. We were incorporated in Australia in April 2014, and in 2015 listed on the ASX under the symbol “MDC.” Our corporate headquarters are located in Australia, and we maintain offices in the United States and Euro... [Read more]

Industry Health Care
Sector Biotechnology
Founded 2014
Employees 42
Stock Exchange NASDAQ
Ticker Symbol MDLB
Full Company Profile

Financial Performance

Financial Statements


Medlab Clinical Ltd. IPO Registration Document (F-1)

Medlab Clinical Ltd. has filed to go public with an IPO on the NASDAQ.

1 year ago - SEC